Prev: Prevalence and sociodemographic correlates of antinuclear antibodies in the United StatesNext: Diagnostic performance of anti-DFS70 antibodies in excluding systemic lupus erythematosus diagnosis: An updated systematic review and meta-analysis
Record 057 · Systematic review · 2021
Anti-DFS70 Antibodies for Differentiating Systemic Autoimmune Rheumatic Disease in Patients with Positive ANA Tests: A Systematic Review and Meta-Analysis
Diagnostics · requested inclusion
“Meta-analysis assessed anti-DFS70 for distinguishing systemic autoimmune rheumatic disease among ANA-positive patients; specificity was high but sensitivity low.”
Meta-analysis assessed anti-DFS70 for distinguishing systemic autoimmune rheumatic disease among ANA-positive patients; specificity was high but sensitivity low. Limits noted in the record: Results depend on the target disease and study population; anti-DFS70 alone does not rule out disease. A positive ANA is not a diagnosis. Claims in this record are not verified.
A positive ANA is not a diagnosis. Claims in this record are not verified.
source
- dfs70
- pattern
- positive-ana
Systematic review
